U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4173141731Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)WithdrawnNo Results AvailableDeath|Postoperative Complications|Myocardial Infarction|Stroke|Renal FailureOther: FACE quality improvement initiative (see below)|Other: Pre-quality improvement initiativehttps://ClinicalTrials.gov/show/NCT02019342
4173241732A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on RisperidoneCompletedNo Results AvailableSchizophreniaOther: Placebo|Drug: RO5545965|Drug: risperidonehttps://ClinicalTrials.gov/show/NCT02019329
4173341733BioSteel Supplementation and PerformanceNot yet recruitingNo Results AvailableFatigueDietary Supplement: BioSteel Sports Drink|Dietary Supplement: Isoenergetic Controlhttps://ClinicalTrials.gov/show/NCT02019316
4173441734Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast CancerRecruitingNo Results AvailableBreast CancerProcedure: FNA and Core biopsyhttps://ClinicalTrials.gov/show/NCT02019303
4173541735A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.WithdrawnNo Results AvailableHealthy VolunteerDrug: Midazolam|Drug: bitopertinhttps://ClinicalTrials.gov/show/NCT02019290
4173641736A Study of Perjeta (Pertuzumab) and Herceptin (Trastuzumab) Treatment in Combination With a Taxane in Patients With Advanced HER2-positive Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Herceptin (trastuzumab)|Drug: Perjeta (pertuzumab)|Drug: Taxane chemotherapyhttps://ClinicalTrials.gov/show/NCT02019277
4173741737A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple RecruitingNo Results AvailableCardiovascular Disease|High Cardiovascular Risk|Obesity|Overweight|Type 2 DiabetesDrug: APD356-Lorcaserin hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02019264
4173841738Lung Transplant Subjects Using 19F MRICompletedNo Results AvailablePost Single or Double Lung TransplantDrug: perfluorinated gas/oxygen mixture|Device: MRIhttps://ClinicalTrials.gov/show/NCT02019251
4173941739Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial FibrillationTerminatedNo Results AvailableAtrial FibrillationOther: Pulmonary Vein Isolation procedurehttps://ClinicalTrials.gov/show/NCT02019238
4174041740A Cluster-randomized, Pragmatic Trial of Hemodialysis Session DurationRecruitingNo Results AvailableEnd Stage Renal DiseaseOther: Dialysis session of at least 4.25 hourshttps://ClinicalTrials.gov/show/NCT02019225
4174141741Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-TetrofosminActive, not recruitingNo Results AvailableCardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT02019212
4174241742Magnetic Resonance Imaging (MRI) in MotionEnrolling by invitationNo Results AvailablePrimary or Metastatic Tumors of the Lungs, Liver or Pancreas.https://ClinicalTrials.gov/show/NCT02019199
4174341743Effects of Vitamin C and E on Endothelial Function in Adolescent DiabetesCompletedNo Results AvailableType 1 Diabetes MellitusDietary Supplement: Vitamin C|Dietary Supplement: Vitamin Ehttps://ClinicalTrials.gov/show/NCT02019186
4174441744Rehabilitation Boot Camp: Intensive Balance and Mobility Therapy for People With Acquired Brain InjuryCompletedNo Results AvailableBrain InjuriesBehavioral: Boot Camp Balance Traininghttps://ClinicalTrials.gov/show/NCT02019173
4174541745Effectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF VarnishRecruitingNo Results AvailableEarly Childhood CariesDrug: 25% AgNO3 solution followed by 5% NaF varnish|Drug: 38% SDF solution followed by placebo varnishhttps://ClinicalTrials.gov/show/NCT02019160
4174641746BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.RecruitingNo Results AvailableHypoxic Ischaemic Encephalopathy (HIE)|Asphyxiahttps://ClinicalTrials.gov/show/NCT02019147
4174741747Effectiveness of App-based Relaxation for Patients With Chronic Neck PainRecruitingNo Results AvailableChronic Neck PainBehavioral: relaxation exercise|Other: ususal carehttps://ClinicalTrials.gov/show/NCT02019134
4174841748Dexmedetomidine and Renal TransplantsActive, not recruitingNo Results AvailableRenal Failurehttps://ClinicalTrials.gov/show/NCT02019121
4174941749Gait Modification Treatment for Knee OsteoarthritisRecruitingNo Results AvailableKnee OsteoarthritisOther: Progressive walking program with toe-out gait modification|Other: Progressive walking programhttps://ClinicalTrials.gov/show/NCT02019108
4175041750Clinical and Biological Markers in Acute Respiratory FailureCompletedNo Results AvailableVentilator-Associated Pneumonia|Acute Respiratory Distress SyndromeOther: Bronchoscopy for the sampling of bronchoalveolar lavage (BAL) fluidhttps://ClinicalTrials.gov/show/NCT02019095
4175141751Electrical Stimulation and Expression of VEGF and NO in Diabetic Foot UlcerCompletedNo Results AvailableDiabetic Foot UlcerDevice: Electrical Stimulation (BTL-5000 series, United Kingdom)|Device: placebohttps://ClinicalTrials.gov/show/NCT02019082
4175241752CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeSuspendedNo Results AvailableAdult Acute Erythroid Leukemia (M6)|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)|Adult Acute Myeloblastic Leukemia With Maturation Drug: liposomal cytarabine-daunorubicin CPX-351|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT02019069
4175341753Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic HepatitisCompletedNo Results AvailableAlcoholic Fatty Liver Disease|Alcoholic HepatitisDrug: Placebo /bid P.O|Drug: MG-1|Drug: MG-2 : MG1000mg, Placebo /bid P.O|Drug: metadoxinehttps://ClinicalTrials.gov/show/NCT02019056
4175441754Evaluation of Enhanced Syphilis Screening Among HIV-positive Men Who Have Sex With MenRecruitingNo Results AvailableSyphilisOther: Syphilis testing with routine HIV bloodworkhttps://ClinicalTrials.gov/show/NCT02019043
4175541755Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization ElectrodeRecruitingNo Results AvailableBenign Prostatic Hyperplasiahttps://ClinicalTrials.gov/show/NCT02019030
4175641756Botox Injection in Treatment of Cluster HeadacheCompletedNo Results AvailableCluster HeadacheDrug: Botulinum Toxin Type A 25 IU|Drug: Botulinum Toxin Type A 50 IUhttps://ClinicalTrials.gov/show/NCT02019017
4175741757A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial WrinklesActive, not recruitingNo Results AvailableWrinklesDrug: Onabotulinum Toxin A|Drug: Incobotulinum Toxin Ahttps://ClinicalTrials.gov/show/NCT02019004
4175841758Late Acquired Malaposition and Different PolymersCompletedNo Results AvailableLate Acquired Stent MalapositionProcedure: Everolimus-Eluting Stent (EES)|Procedure: Zotarolimus-Eluting-Stent (ZES)|Procedure: Biolimus-Eluting-Stent (BES)https://ClinicalTrials.gov/show/NCT02018991
4175941759Comprehensive Triaged HIV Prevention in TanzaniaActive, not recruitingNo Results AvailableHIVBehavioral: Comprehensive Triaged HIV Prevention (CTHP)https://ClinicalTrials.gov/show/NCT02018978
4176041760Niacin on Immune Activation : a Proof-of-concept StudyActive, not recruitingNo Results AvailableHIVDrug: Niacin|Drug: Niacinhttps://ClinicalTrials.gov/show/NCT02018965

* Görseller ve İçerik tekif hakkına sahip olabilir